A novel linker-immunodominant site (LIS) vaccine targeting the SARS-CoV-2 spike protein protects against severe COVID-19 in Syrian hamstersBao‐Zhong Zhang, Jian‐Dong Huang, Chris Chung‐Sing Chan et al.|Emerging Microbes & Infections|2021Cited by 15